A detailed history of Keebeck Alpha, LP transactions in Surmodics Inc stock. As of the latest transaction made, Keebeck Alpha, LP holds 8,464 shares of SRDX stock, worth $288,368. This represents 0.36% of its overall portfolio holdings.

Number of Shares
8,464
Previous 48,591 82.58%
Holding current value
$288,368
Previous $1.88 Million 82.22%
% of portfolio
0.36%
Previous 1.25%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 03, 2025

SELL
$37.5 - $40.13 $1.5 Million - $1.61 Million
-40,127 Reduced 82.58%
8,464 $335,000
Q3 2024

Oct 31, 2024

BUY
$38.47 - $42.24 $1.87 Million - $2.05 Million
48,591 New
48,591 $1.88 Million

Others Institutions Holding SRDX

About SURMODICS INC


  • Ticker SRDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 14,005,000
  • Market Cap $477M
  • Description
  • Surmodics, Inc., together with its subsidiaries, provides surface modification technologies for intravascular medical devices, and chemical components for in vitro diagnostic immunoassay tests and microarrays in the United States and internationally. It operates in two segments, Medical Device and In Vitro Diagnostics (IVD). The Medical Device s...
More about SRDX
Track This Portfolio

Track Keebeck Alpha, LP Portfolio

Follow Keebeck Alpha, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Keebeck Alpha, LP, based on Form 13F filings with the SEC.

News

Stay updated on Keebeck Alpha, LP with notifications on news.